AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Lineage Cell Therapeutics Inc. Director's Dealing 2017

Jan 11, 2017

6895_rns_2017-01-11_c2a55443-561e-4db1-8cfa-239687315473.htm

Director's Dealing

Opens in your device viewer

_________ false


��	2 352
.BIOTIME, INC
Corporation no: 876343	10834
- - -


	Israel Securities Authority			Tel Aviv Stock Exchange		C004 ( Public )		Reported via MAGNA:	11/01/2017
	www.isa.gov.il			www.tase.co.il				Reference:	2017-02-004165	Time of broadcast: 15:37 15:37:04

Immediate report on other matterDon't use this form if there is more adequate one


(Form 5) ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES �� , KINGSLEY ALFRED D
Attached file form5_2_isa.pdf



References of previous documents relating to this matter(the reference does not constitute incorporation by reference):


- - -
Stock Exchange/Market: -1	Date of revision of form structure: 29/12/2016
Address: HARBOR BAY PARKWAY 1301 , ALAMEDA 94502 CALIFORNIA , U.S.A Tel: 5105213390 , Fax: 5105213389
E-mail address: [email protected] Company site: biotimeinc.com

Previous names of reporting entity:

Name of the Signatory: Gerzi Ilan Position of Signatory in the reporting corporation: Attorney/Legal Counsel Name of Employer Company: PEARL COHEN ZEDEK LATZER BARATZ
Address: Harbor Bay Parkway 1301 , Alameda 94502 Telephone: 510-5213390 Facsimile: 510-5213389 E-mail: [email protected] 1
U.S.A